Why the study?
Although Korean guidelines for chronic heart failure were introduced in March 2016, chronic and acute heart failure represent distinct entities, driving an increasing need for specific guidelines for acute heart failure management.
The KSHF Part III guidelines provide tailored, evidence-based recommendations for managing acute heart failure according to specific etiologies and comorbidities in the Korean population.
Answers are grounded in this paper and cite their sources.
Informs etiology-specific acute HF management now; extends prior guidelines with Korean comorbidity-focused recommendations.
The prevalence of heart failure (HF) is on the rise due to the aging of society. Furthermore, the continuous progress and widespread adoption of screening and diagnostic strategies have led to an increase in the detection rate of HF, effectively increasing the number of patients requiring monitoring and treatment. Because HF is associated with substantial rates of mortality and morbidity, as well as high socioeconomic burden, there is an increasing need for developing specific guidelines for HF management. The Korean guidelines for the diagnosis and management of chronic heart failure (CHF) were introduced in March 2016. However, CHF and acute heart failure (AHF) represent distinct disease entities. Here, we introduce the Korean guidelines for the management of AHF with reduced or preserved ejection fraction. Part III of this guideline covers management strategies optimized according to the etiology of AHF and the presence of co-morbidities.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) conducted a review in Acute Heart Failure. The Korean Society of Heart Failure guidelines provide specific management strategies for acute heart failure optimized according to etiologies and co-morbidities.
Synapse has enriched 10 related papers. Consider them for comparative context: